<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR314.html">Part 314
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 314.410  Imports and exports of new drugs.
                            </h3>
                            <p class="depth1"><em>(a)</em> Imports. </p><p class="depth2"><em>(1)</em> A new drug may be imported into the United States  if: (i) It is the subject of an approved application under this part; or  (ii) it complies with the regulations pertaining to investigational new  drugs under part 312; and it complies with the general regulations  pertaining to imports under subpart E of part 1.</p><p class="depth2"><em>(2)</em> A drug substance intended for use in the manufacture,  processing, or repacking of a new drug may be imported into the United  States if it complies with the labeling exemption in Sec. 201.122  pertaining to shipments of drug substances in domestic commerce.</p><p class="depth1"><em>(b)</em> Exports. </p><p class="depth2"><em>(1)</em> A new drug may be exported if it is the subject of  an approved application under this part or it complies with the  regulations pertaining to investigational new drugs under part 312.</p><p class="depth2"><em>(2)</em> A new drug substance that is covered by an application approved  under this part for use in the manufacture of an approved drug product  may be exported by the applicant or any person listed as a supplier in  the approved application, provided the drug substance intended for  export meets the specification of, and is shipped with a copy of the  labeling required for, the approved drug product.</p><p class="depth2"><em>(3)</em> Insulin or an antibiotic drug may be exported without regard to  the requirements in section 802 of the act if the insulin or antibiotic  drug meets the requirements of section 801(e)(1) of the act.  [50 FR 7493, Feb. 22, 1985. Redesignated at 57 FR 17983, Apr. 28, 1992,  and amended at 64 FR 402, Jan. 5, 1999; 69 FR 18766, Apr. 8, 2004]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
